Embio Diagnostics
$2.7M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Embio Diagnostics is currently valued at N/A as of November 15, 2024. The company has raised a total of $3.8M in funding.
Investment Perspective
Embio Diagnostics's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Embio Diagnostics Worth in 2025?
As of 2025, Embio Diagnostics is valued at N/A, based on the company's Seed Round funding round in November 15, 2024. This valuation positions Embio Diagnostics as one of the leading private companies in the sector.
Embio Diagnostics Valuation History
Embio Diagnostics's funding history demonstrates steady growth and investor confidence.
How Embio Diagnostics Valuation is Determined
Private company valuations like Embio Diagnostics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Embio Diagnostics Valuation FAQs
Is Embio Diagnostics profitable?
Embio Diagnostics has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Embio Diagnostics's valuation compare to competitors?
Embio Diagnostics is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Embio Diagnostics IPO?
Embio Diagnostics has not announced plans for an initial public offering. Until an IPO, investors can access Embio Diagnostics shares through secondary market platforms.